Clinical trial: Gastric acid suppression in Hispanic adults with symptomatic gastro-oesophageal reflux disease - Comparator study of esomeprazole, lansoprazole and pantoprazole Academic Article uri icon

Overview

MeSH Major

  • 2-Pyridinylmethylsulfinylbenzimidazoles
  • Anti-Ulcer Agents
  • Esomeprazole
  • Gastroesophageal Reflux
  • Hispanic Americans

abstract

  • Esomeprazole was more effective than lansoprazole and pantoprazole in suppressing gastric acidity at both intragastric distal and proximal (area of the acid pocket) sites in Hispanics with GERD. Future studies are warranted to understand better the role of the acid pocket in GERD (Clinical trial numbers: D9612L00106; ClinicalTrials.gov: NCT00410592).

publication date

  • July 15, 2010

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1111/j.1365-2036.2010.04335.x

PubMed ID

  • 20456300

Additional Document Info

start page

  • 200

end page

  • 8

volume

  • 32

number

  • 2